Approval · Notice of Compliance 48 · 2003
THYMOGLOBULIN: Notice of Compliance 48
Issued August 13, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 48
- Date
- August 13, 2003
- Company
- Sangstat Medical Corporation
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New manufacturing process
- Therapeutic class
- Immumosuppressant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| THYMOGLOBULIN | Not yet assigned | — |
Medicinal ingredients
- ANTI-THYMOCYTE GLOBULIN (RABBIT) 25 MG per VIAL